LOADING
Comparing Tesla Inc (TSLA) and Merck & Company (MRK) across the Consumer Discretionary and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | TSLA | MRK |
|---|---|---|
| Price | $396.18 | $120.78 |
| Change Today | +0.36% | -2.62% |
| Market Cap | $1.53T | $305.1B |
| P/E Ratio | 370.7 | 34.8 |
| Forward P/E | 178.6 | 24.4 |
| PEG Ratio | 5.11 | 6.10 |
| EPS | $1.10 | $3.55 |
| Revenue Growth (YoY) | 15.8% | 4.9% |
| Profit Margin | 4.0% | 13.6% |
| Return on Equity | 4.9% | 18.9% |
| Dividend Yield | -- | 2.62% |
| Beta | 1.80 | 0.20 |
| 52-Week High | $498.83 | $130.29 |
| 52-Week Low | $297.82 | $74.18 |
| Volume | 23.4M | 9.9M |
Tesla Inc is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.